The effect of food on the pharmacokinetics of ofloxacin
- PMID: 3460737
- DOI: 10.1185/03007998609110436
The effect of food on the pharmacokinetics of ofloxacin
Abstract
After oral administration of a single dose of ofloxacin (300 mg), with and without a standard breakfast, to 12 healthy male volunteers in an open, randomized crossover study, concentrations of the unchanged drug were estimated at various times in serum and urine, over 28 hours and 48 hours, respectively. Each dose was followed by a wash-out period of 1 week. Ofloxacin concentrations were determined using high pressure liquid chromatography (HPLC): parallel determinations using a microbiological assay were in close agreement. Maximum serum concentrations (Cmax) of ofloxacin, after fasting and with breakfast, respectively, were 3.7 and 3.1 micrograms/ml (HPLC, median values). The corresponding areas under the serum concentration-time curves (AUC0-28) were 29.9 and 24.5 micrograms/ml. The lower values of Cmax and AUC0-28 found after food intake were statistically significant (p less than 0.05) but not clinically relevant when compared to the fasting values. Time to reach Cmax and terminal elimination half-life (t1/2 beta) were not significantly affected by food intake: t1/2 beta was calculated as 5.3 and 5.9 hours (HPLC, median values), fasting and with breakfast, respectively. Urinary recovery (after 48 hours: 72% and 74%, respectively) was also not significantly affected by food intake, and urinary concentrations of ofloxacin remained far above 1 microgram/ml, i.e. above the minimum inhibitory concentration (MIC90) for most bacterial strains, for at least 48 hours after drug administration. General tolerability was good; no side-effects were reported.
Similar articles
-
Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.Pharmatherapeutica. 1985;4(6):376-82. Pharmatherapeutica. 1985. PMID: 3866256 Clinical Trial.
-
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.Clin Ther. 1986;8(6):632-45. Clin Ther. 1986. PMID: 3466701
-
Relative bioavailability of ofloxacin tablets in comparison to oral solution.Curr Med Res Opin. 1987;10(8):514-20. doi: 10.1185/03007998709108959. Curr Med Res Opin. 1987. PMID: 3479296 Clinical Trial.
-
Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.Chemioterapia. 1986 Dec;5(6):391-3. Chemioterapia. 1986. PMID: 3467875
-
The pharmacokinetics and tissue penetration of ofloxacin.J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647. J Antimicrob Chemother. 1984. PMID: 6596301
Cited by
-
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.Antimicrob Agents Chemother. 1990 Jan;34(1):78-81. doi: 10.1128/AAC.34.1.78. Antimicrob Agents Chemother. 1990. PMID: 2327762 Free PMC article.
-
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28. Clin Pharmacokinet. 2024. PMID: 38807006 Free PMC article.
-
Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.Drugs. 1987;34 Suppl 1:62-70. doi: 10.2165/00003495-198700341-00014. Drugs. 1987. PMID: 3481330
-
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1987 Apr;33(4):346-91. doi: 10.2165/00003495-198733040-00003. Drugs. 1987. PMID: 3297617 Review.
-
Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.Antimicrob Agents Chemother. 1995 Sep;39(9):2135-7. doi: 10.1128/AAC.39.9.2135. Antimicrob Agents Chemother. 1995. PMID: 8540731 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources